Poor Science; Poorly Trained Scientists; Poor Policies: Major Deterrents to the War on Cancer
- Authors
-
-
Leslie C. Costello
School of Dentistry Department of Oncology and Diagnostic Sciences and the Greenebaum Cancer Center, University of Maryland, Baltimore, Maryland 21201, USA
-
- Keywords:
- Cancer, NIH policies, training of scientists, excessive molecular biology, holistic physiological/pathophysiological approach.
- Abstract
-
Although the availability of funding has been described as the major limitation on advances in cancer, the progress in the war on cancer has been deterred mainly by poor science, poorly trained scientists, and poor NIH policies. This is the result of NIH policies of its extreme focus on molecular biology (genomics, molecular genetics, molecular biology) identification of the molecular factors and pathways; which are required for the acceptability of treatment and preventive protocols. As such, this has influenced virtually all agencies that provide grants for medical research to adopt the NIH policies. This has impacted the funding of the research as well as the focus of the training of scientists. Directors of NCI Dr. Varmus (also Nobel Prize awardee) and Dr. Zerhouni had addressed this issue; and they rejected the necessity of molecular biology studies and information. NIH should return to the holistic physiological/pathophysiological approach to studies of cancer issues. This would provide the best approach for winning the war on cancer.
- Downloads
-
Download data is not yet available.
- References
-
Zerhouni E. The NIH roadmap. Science 2003; 332: 63-5. https://doi.org/10.1126/science.1091867
Leaf C. Why we're losing the war on cancer (and how to win it). Fortune 2004; 149(6): 76-82.
Costello LC. The effect of contemporary education and training of biomedical scientists on present and future medical research. Acad Med 2009; 84: 459-63. https://doi.org/10.1097/ACM.0b013e31819a7c6b
Perspective: Is NIH funding the "best science by the best scientists"? A critique of the NIH R01 research grant review policies. Acad Med 2010; 85(5): 775-9. https://doi.org/10.1097/ACM.0b013e3181d74256
National Institutes of Health. Enhancing Peer Review at NIH: Overview. Available at: http://enhancing-peer-review.nih.gov/index.html. Accessed January 18, 2010
Office of Extramural Research, National Institutes of Health. Encouraging Early Transition to Research Independence: Modifying the NIH New Investigator Policy to Identify Early Stage Investigators. Available at: http://grants.nih.gov/grants/guide/notice-files/NOT-OD-08-121.html. Accessed January 18, 2010.
Bernard C. An Introduction to the Study of Experimental Medicine. New York, NY: The Macmillan Company 1927.
- Downloads
- Published
- 15-08-2018
- Issue
- Vol. 7 No. 3 (2018)
- Section
- Articles
How to Cite
Similar Articles
- Amoura Abouelnaga, Ghada A. Mutawa, Hassan Abdelghaffar, Mohamed Sobh, Sahar Hamed, Shaker A. Mousa, Establishment and Characterization of Primary Human Ovarian Cancer Stem Cell Line (CD44+ve) , Journal of Cancer Research Updates: Vol. 5 No. 2 (2016)
- Kenji Ina, Yuko Kato, Kengo Nanya, Satoshi Hibi, Yuko Shirokawa, Tomoko Toda, Satoshi Kayukawa, Adaptation to the Progress in Cancer Genomic Medicine by a Japanese Community Hospital , Journal of Cancer Research Updates: Vol. 12 (2023)
- Joseph V. Pergolizzi Jr., Robert B. Raffa, Emilio Esteban Gonzalez, Jo Ann LeQuang, A Guide for Cancer Pain Management in Latin America , Journal of Cancer Research Updates: Vol. 6 No. 4 (2017)
- Willy Ramos, Víctor Juan Vera-Ponce, Rubén Espinoza, Nadia Guerrero, Zoila Moreno Garrido, Fiorella E. Zuzunaga-Montoya, Ericson L. Gutierrez, Non-Performance of Cancer Screening in Peru: A Comparative Analysis between Regions Exposed and Unexposed to Ozone Layer Mini-Hole , Journal of Cancer Research Updates: Vol. 14 (2025)
- Joseph V. Pergolizzi Jr, Robert Taylor Jr, Gianpietro Zampogna, Fuat H. Demirelli, Serdar Erdine, Robert B. Raffa, Oxycodone Immediate Release for Cancer Pain Management in Turkey: Maximizing Value in Opioid Analgesics , Journal of Cancer Research Updates: Vol. 3 No. 4 (2014)
- Jianwei Zhao, Yongxiu Chen, Xiaoxiao Lu, Di Wu, Jiansong Chen, Zhihuang Chen, Lin Liu, Lei Yang, Lan Zhang, Yifeng Zhou, Jiachun Lu, The Polymorphism of EME1 Gene is Associated with an Increased Risk of Lung Cancer: A Case-Control Study from Chinese Population , Journal of Cancer Research Updates: Vol. 3 No. 4 (2014)
- Umesh C. Gupta, Subhas C. Gupta, Shayle S. Gupta, The Under appreciated Role of Lifestyle and Nutrition in Cancer Prevention, Genesis, and Treatment , Journal of Cancer Research Updates: Vol. 7 No. 4 (2018)
- F. Gloria-Bottini, M. Nicotra, C. Spina, P.L. Benedetti-Panici, P. Saccucci, A. Neri, A. Magrini, E. Bottini, P53 Codon 72 and Endometrium Cancer , Journal of Cancer Research Updates: Vol. 4 No. 4 (2015)
- Satoshi Hibi, Yuko Shirokawa, Kengo Nanya, Tatsuya Kawamura, Yuko Kato, Shu Yuasa, Satoshi Kayukawa, Kenji Ina, Evaluation of HBV-DNA Monitoring after Completion of Chemotherapy using a PDCA Cycle following Introduction of a Support System Provided by a Multidisciplinary Team of Quality Management in Cancer Medicine , Journal of Cancer Research Updates: Vol. 14 (2025)
- Michael T. Hardin, Amy S. Harrison, Virginia L. Lockamy, Jun Li, Cheng Peng, Peter Potrebko, Yan Yu, Laura Doyle, Junsheng Cao, Evaluation of the Type and Frequency of Errors Discovered During Routine Secondary Patient Chart Review , Journal of Cancer Research Updates: Vol. 6 No. 1 (2017)
You may also start an advanced similarity search for this article.